Abstract
Interest in deep brain stimulation (DBS) for treatment-refractory psychiatric disorders has raised ethical concerns about the adequacy of safeguards for human subjects. The nature of DBS and potential vulnerability of participants have raised worries about whether study participants have capacity to give informed consent (including understanding the risks associated with DBS and the likelihood of personal benefit), and can appropriately distinguish between DBS research and clinical care. Empirical inquiry into these concerns suggests that the vast majority of prospective participants under consideration for early trials of DBS for treatment-resistant depression (TRD) had adequate decisional capacity. While these patients considered DBS for various and often unique reasons, most understood the risks and had reasonable expectations of benefit. These results suggest that given appropriate procedures, patients with TRD can provide informed consent to DBS research. Further attention is needed to understand patients’ considerations for DBS research, and to evaluate procedures to enhance appreciation of distinctions between research and clinical contexts. Similar inquiry on DBS research for other psychiatric disorders is needed, particularly because greater cognitive impairment is associated with worse performance on measures of decisional capacity. Safeguards such as surrogate consent should be considered (and their use reported) when studies enroll patients with cognitive disorders, such as Alzheimer’s disease and other dementias. Research is needed into whether patients with obsessive-compulsive disorder are more likely than those with depression to lack adequate capacity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Advanced Neuromodulation Systems, Inc. (2009). Broaden clinical study.
Appelbaum, P. S., & Grisso, T. (2001). MacCAT-CR: MacArthur Competence Assessment Tool for Clinical Research. Sarasota, FL: Professional Resource Press.
Appelbaum, P. S., Grisso, T., Frank, E., O’Donnell, S., & Kupfer, D. J. (1999). Competence of depressed patients for consent to research. American Journal of Psychiatry, 156(9), 1380–1384.
Appelbaum, P. S., Lidz, C. W., & Grisso, T. (2004). Therapeutic misconception in clinical research: Frequency and risk factors. IRB, 26(2), 1–8.
Bell, E., Mathieu, G., & Racine, E. (2009). Preparing the ethical future of deep brain stimulation. Surgical Neurology, 72(6), 577–586. doi:10.1016/j.surneu.2009.03.029. S0090-3019(09)00285-7 [pii].
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Schlaepfer, T. E. (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry, 67(2), 110–116. doi:10.1016/j.biopsych.2009.09.013, S0006-3223(09)01094-4 [pii].
Black, B. S., Rabins, P. V., Sugarman, J., & Karlawish, J. H. (2010). Seeking assent and respecting dissent in dementia research. American Journal of Geriatric Psychiatry, 18(1), 77–85. doi:10.1097/JGP.0b013e3181bd1de2.
Candilis, P. J., Fletcher, K. E., Geppert, C. M., Lidz, C. W., & Appelbaum, P. S. (2008). A direct comparison of research decision-making capacity: Schizophrenia/schizoaffective, medically ill, and non-ill subjects. Schizophrenia Research, 99(1–3), 350–358. doi:10.1016/j.schres.2007.11.022. S0920-9964(07)00534-8 [pii].
Christopher, P. P., Leykin, Y., Appelbaum, P. S., Holtzheimer, P. E., 3rd, Mayberg, H. S., & Dunn, L. B. (2012). Enrolling in deep brain stimulation research for depression: Influences on potential subjects’ decision making. Depression and Anxiety, 29, 139–146. doi:10.1002/da.20916.
Cicek, E., Cicek, I. E., Kayhan, F., Uguz, F., & Kaya, N. (2013). Quality of life, family burden and associated factors in relatives with obsessive-compulsive disorder. General Hospital Psychiatry, 35(3), 253–8. doi:10.1016/j.genhosppsych.2013.01.004. S0163-8343(13)00009-1 [pii].
Cohen, B. J., McGarvey, E. L., Pinkerton, R. C., & Kryzhanivska, L. (2004). Willingness and competence of depressed and schizophrenic inpatients to consent to research. Journal of the American Academy of Psychiatry and the Law, 32(2), 134–143.
Daugherty, C., Ratain, M. J., Grochowski, E., Stocking, C., Kodish, E., Mick, R., & Siegler, M. (1995). Perceptions of cancer patients and their physicians involved in phase i trials. Journal of Clinical Oncology, 13(5), 1062–1072.
Daugherty, C. K., Banik, D. M., Janish, L., & Ratain, M. J. (2000). Quantitative analysis of ethical issues in phase i trials: A survey interview of 144 advanced cancer patients. IRB, 22(3), 6–14.
Deuschl, G., Herzog, J., Kleiner-Fisman, G., Kubu, C., Lozano, A. M., Lyons, K. E., Voon, V. (2006a). Deep brain stimulation: Postoperative issues. Movement Disorders, 21(Suppl. 14), S219–S237.
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schafer, H., Botzel, K., Voges, J. (2006b). A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine, 355(9), 896–908.
Dunn, L. B., Candilis, P. J., & Roberts, L. W. (2006a). Emerging empirical evidence on the ethics of schizophrenia research. Schizophrenia Bulletin, 32(1), 47–68. doi:10.1093/schbul/sbj012.
Dunn, L. B., Palmer, B. W., Keehan, M., Jeste, D. V., & Appelbaum, P. S. (2006b). Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. American Journal of Psychiatry, 163(3), 500–506. doi:10.1176/appi.ajp.163.3.500.
Dunn, L. B., Palmer, B. W., Appelbaum, P. S., Saks, E. R., Aarons, G. A., & Jeste, D. V. (2007). Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: Differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophrenia Research, 89(1–3), 110–118. doi:10.1016/j.schres.2006.08.005.
Dunn, L. B., Holtzheimer, P. E., 3rd, Hoop, J. G., Mayberg, H., Roberts, L. W., & Appelbaum, P.S. (2011). Ethical issues in deep brain stimulation research for treatment-resistant depression: Focus on risk and consent. AJOB Neuroscience, 2, 29–36.
Dunn, L. B., Fisher, S. R., Hantke, M., Appelbaum, P. S., Dohan, D., Young, J. P., & Roberts, L. W. (2013). “Thinking about it for somebody else”: Alzheimer’s disease research and proxy decision makers’ translation of ethical principles into practice. American Journal of Geriatric Psychiatry 21, 337–345. doi:10.1097/JGP.0b013e31824362ca
Elliott, C. (1997). Caring about risks: Are severely depressed patients competent to consent to research? Archives of General Psychiatry, 54, 113–116.
Farris, S., Vitek, J., & Giroux, M. L. (2008). Deep brain stimulation hardware complications: The role of electrode impedance and current measurements. Movement Disorders, 23(5), 755–760. doi:10.1002/mds.21936.
Fins, J. J., Mayberg, H. S., Nuttin, B., Kubu, C. S., Galert, T., Sturm, V., Schlaepfer, T. E. (2011a). Misuse of the FDA’S humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Affairs, 30(2), 302–311. doi:10.1377/hlthaff.2010.0157, 30/2/302 [pii]
Fins, J. J., Schlaepfer, T. E., Nuttin, B., Kubu, C. S., Galert, T., Sturm, V., Mayberg, H. S. (2011b). Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. Journal of Neural Engineering, 8(3), 033001. doi:10.1088/1741-2560/8/3/033001, S1741-2560(11)82782-5 [pii].
Fisher, C. E., Dunn, L. B., Christopher, P. P., Holtzheimer, P. E., Leykin, Y., Mayberg, H. S., Appelbaum, P. S. (2012). The ethics of research on deep brain stimulation for depression: Decisional capacity and therapeutic misconception. Annals of the New York Academy of Sciences, 1265, 69–79. doi:10.1111/j.1749-6632.2012.06596.x.
Flaherty, A. W., Williams, Z. M., Amirnovin, R., Kasper, E., Rauch, S. L., Cosgrove, G. R., & Eskandar, E. N. (2005). Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: Technical case report. Neurosurgery, 57(Suppl. 4), E403, 00006123-200510004-00029 [pii]; discussion E403.
Goodman, W. K., Foote, K. D., Greenberg, B. D., Ricciuti, N., Bauer, R., Ward, H., Okun, M. S. (2010). Deep brain stimulation for intractable obsessive compulsive disorder: Pilot study using a blinded, staggered-onset design. Biological Psychiatry, 67(6), 535–542. doi:10.1016/j.biopsych.2009.11.028, S0006-3223(09)01426-7 [pii].
Greenberg, B. D., Malone, D. A., Friehs, G. M., Rezai, A. R., Kubu, C. S., Malloy, P. F., Rasmussen, S. A. (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology, 31(11), 2384–2393.
Greenberg, B. D., Gabriels, L. A., Malone, D. A., Jr., Rezai, A. R., Friehs, G. M., Okun, M. S., Nuttin, B. J. (2008). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Molecular Psychiatry, 15(1):64–79. doi:10.1038/mp.2008.55, mp200855 [pii].
Grisso, T., & Appelbaum, P. S. (1995). The MacArthur treatment competence study. III: Abilities of patients to consent to psychiatric and medical treatments. Law and Human Behavior, 19(2), 149–174.
Hamani, C., McAndrews, M. P., Cohn, M., Oh, M., Zumsteg, D., Shapiro, C. M., Lozano, A. M. (2008). Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Annals of Neurology, 63(1), 119–123. doi:10.1002/ana.21295
Hare, J., Pratt, C., & Nelson, C. (1992). Agreement between patients and their self-selected surrogates on difficult medical decisions. Archives of Internal Medicine, 152(5), 1049–1054.
Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013). Alzheimer disease in the United States (2010–2050) estimated using the 2010 Census. Neurology, 80(19), 1778–83. doi:10.1212/WNL.0b013e31828726f5. WNL.0b013e31828726f5 [pii].
Henderson, G. E., Easter, M. M., Zimmer, C., King, N. M., Davis, A. M., Rothschild, B. B., Nelson, D. K. (2006). Therapeutic misconception in early phase gene transfer trials. Social Science and Medicine, 62(1), 239–253.
Herzog, J., Volkmann, J., Krack, P., Kopper, F., Potter, M., Lorenz, D., Deuschl, G. (2003). Two-year follow-up of subthalamic deep brain stimulation in Parkinson’s disease. Movement Disorders, 18(11), 1332–1337
Hirschman, K. B., Kapo, J. M., & Karlawish, J. H. (2006). Why doesn’t a family member of a person with advanced dementia use a substituted judgment when making a decision for that person? American Journal of Geriatric Psychiatry, 14(8), 659–667.
Holtzheimer, P. E., & Mayberg, H. S. (2011). Deep brain stimulation for psychiatric disorders. Annual Review of Neuroscience, 34, 289–307. doi:10.1146/annurev-neuro-061010-113638.
Holtzheimer, P. E., Kelley, M. E., Gross, R. E., Filkowski, M. M., Garlow, S. J., Barrocas, A., Mayberg, H. S. (2012). Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Archives of General Psychiatry, 69(2), 150–158. doi:10.1001/archgenpsychiatry.2011.1456.
Jeste, D. V., Depp, C. A., & Palmer, B. W. (2006). Magnitude of impairment in decisional capacity in people with schizophrenia compared to normal subjects: An overview. Schizophrenia Bulletin, 32(1), 121–128.
Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M. (2011). Deep brain stimulation for treatment-resistant depression: Follow-up after 3 to 6 years. American Journal of Psychiatry, 168(5), 502–510. doi:10.1176/appi.ajp.2010.10081187. appi.ajp.2010.10081187 [pii].
Kim, S. Y. (2006). When does decisional impairment become decisional incompetence? Ethical and methodological issues in capacity research in schizophrenia. Schizophrenia Bulletin, 32(1), 92–97.
Kim, S. Y., & Caine, E. D. (2002). Utility and limits of the mini mental state examination in evaluating consent capacity in Alzheimer’s disease. Psychiatric Services, 53(10), 1322–1324.
Lapid, M. I., Rummans, T. A., Poole, K. L., Pankratz, V. S., Maurer, M. S., Rasmussen, K. G., Appelbaum, P. S. (2003). Decisional capacity of severely depressed patients requiring electroconvulsive therapy. The Journal of ECT, 19(2), 67–72.
Laxton, A. W., & Lozano, A. M. (2012). Deep brain stimulation for the treatment of Alzheimer disease and dementias. World Neurosurgery. doi:10.1016/j.wneu.2012.06.028.
Laxton, A. W., Tang-Wai, D. F., McAndrews, M. P., Zumsteg, D., Wennberg, R., Keren, R., Lozano, A. M. (2010). A phase i trial of deep brain stimulation of memory circuits in Alzheimer’s disease. Annals of Neurology, 68(4), 521–534. doi:10.1002/ana.22089.
Leykin, Y., Christopher, P. P., Holtzheimer, P. E., Appelbaum, P. S., Mayberg, H. S., Lisanby, S. H., & Dunn, L. B. (2011). Participants’ perceptions of deep brain stimulation research for treatment-resistant depression: Risks, benefits, and therapeutic misconception. AJOB Primary Research, 2, 33–41.
Lipsman, N., Giacobbe, P., Bernstein, M., & Lozano, A. M. (2012). Informed consent for clinical trials of deep brain stimulation in psychiatric disease: Challenges and implications for trial design. Journal of Medical Ethics, 38, 107–111. doi:10.1136/jme.2010.042002.
Lipsman, N., Woodside, D. B., Giacobbe, P., Hamani, C., Carter, J. C., Norwood, S. J., Lozano, A. M. (2013). Subcallosal cingulate deep brain stimulation for treatment-refractory anorexia nervosa: A phase 1 pilot trial. Lancet, 381(9875):1361–1370. doi:10.1016/S0140-6736(12)62188-6, S0140-6736(12)62188-6 [pii].
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry, 64(6), 461–467.
Lozano, A. M., Giacobbe, P., Hamani, C., Rizvi, S. J., Kennedy, S. H., Kolivakis, T. T., Mayberg, H. S. (2012). A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. Journal of Neurosurgery, 116(2), 315–322. doi:10.3171/2011.10.JNS102122.
Lyons, M. K. (2011). Deep brain stimulation: Current and future clinical applications. Mayo Clinic Proceedings, 86(7), 662–672. doi:10.4065/mcp.2011.0045.
Malone, D. A., Jr., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Greenberg, B. D. (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biological Psychiatry, 65(4), 267–275.
Markarian, Y., Larson, M. J., Aldea, M. A., Baldwin, S. A., Good, D., Berkeljon, A., McKay, D. (2010). Multiple pathways to functional impairment in obsessive-compulsive disorder. Clinical Psychology Review, 30(1), 78–88. doi:10.1016/j.cpr.2009.09.005, S0272-7358(09)00136-6 [pii].
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Kennedy, S. H. (2005). Deep brain stimulation for treatment-resistant depression. Neuron, 45(5), 651–660.
MedtronicNeuro. (2009). Reclaim deep brain stimulation clinical study for treatment-resistant depression. Clinicaltrials.Gov identifier. Nct00837486.
Michels, R. (2004). Research on persons with impaired decision making and the public trust. The American Journal of Psychiatry, 161(5), 777–779.
National Bioethics Advisory, Commission. (1998). Research involving persons with mental disorders that may affect decision-making capacity. Rockville, MD.: National Bioethics Advisory Commission.
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1978). Report and Recommendations: Research Involving Those Institutionalized As Mentally Infirm. Washington, D.C.: U.S. Government Printing Office, 1978. DHEW Publication No. (OS) 78–0006.
Nurgat, Z. A., Craig, W., Campbell, N. C., Bissett, J. D., Cassidy, J., & Nicolson, M. C. (2005). Patient motivations surrounding participation in phase i and phase ii clinical trials of cancer chemotherapy. British Journal of Cancer, 92(6), 1001–1005. doi:10.1038/sj.bjc.6602423. 6602423 [pii].
Overton, E., Appelbaum, P. S., Fisher, S. R., Dohan, D., Roberts, L. W., & Dunn, L. B. (2012). Alternative decision-makers’ perspectives on assent and dissent for dementia research. American Journal of Geriatric Psychiatry, 21(4), 346–354. doi:10.1097/JGP.0b013e318265767e.
Palmer, B. W., & Savla, G. N. (2007). The association of specific neuropsychological deficits with capacity to consent to research or treatment. Journal of International Neuropsychological Society, 13(6), 1047–1059.
Palmer, B. W., Dunn, L. B., Appelbaum, P. S., & Jeste, D. V. (2004). Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Archives of General Psychiatry, 61(3), 230–236. doi:10.1001/archpsyc.61.3.230.
Rabins, P., Appleby, B. S., Brandt, J., DeLong, M. R., Dunn, L. B., Gabriels, L., Mathews, D. J. (2009). Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Archives of General Psychiatry, 66(9), 931–937. doi:10.1001/archgenpsychiatry.2009.113
Racine, E., Waldman, S., Palmour, N., Risse, D., & Illes, J. (2007). “Currents of hope”: Neurostimulation techniques in U.S. and U.K. print media. Cambridge Quarterly of Healthcare Ethics, 16(3), 312–316.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Fava, M. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. American Journal of Psychiatry, 163(11), 1905–1917.
Saks, E. R., Dunn, L. B., Wimer, J., Gonzales, M., & Kim, S. (2008). Proxy consent to research: The legal landscape. Yale Journal of Health Policy, Law, and Ethics, 8(1), 37–92.
Schlaepfer, T. E., & Fins, J. J. (2010). Deep brain stimulation and the neuroethics of responsible publishing: When one is not enough. JAMA, 303(8), 775–776. doi:10.1001/jama.2010.140. 303/8/775 [pii].
Schlaepfer, T. E., Lisanby, S. H., & Pallanti, S. (2010). Separating hope from hype: Some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. CNS Spectrums, 15(5), 285–287.
Schuepbach, W. M., Rau, J., Knudsen, K., Volkmann, J., Krack, P., Timmermann, L., Deuschl, G. (2013). Neurostimulation for Parkinson’s disease with early motor complications. New England Journal of Medicine, 368(7), 610–622. doi:10.1056/NEJMoa1205158.
Seckler, A. B., Meier, D. E., Mulvihill, M., & Paris, B. E. (1991). Substituted judgment: How accurate are proxy predictions? Annals of Internal Medicine, 115(2), 92–98.
Shalowitz, D. I., Garrett-Mayer, E., & Wendler, D. (2006). The accuracy of surrogate decision makers: A systematic review. Archives of Internal Medicine, 166(5), 493–497.
Shannon-Dorcy, K., & Drevdahl, D. J. (2011). “I had already made up my mind”: Patients and caregivers’ perspectives on making the decision to participate in research at a us cancer referral center. Cancer Nursing, 34(6), 428–433. doi:10.1097/NCC.0b013e318207cb03.
Siegfried, J., Lazorthes, Y., & Sedan, R. (1980). Indications and ethical considerations of deep brain stimulation. Acta Neurochirurgica Supplement, 30, 269–274.
Stroup, S., Appelbaum, P., Swartz, M., Patel, M., Davis, S., Jeste, D., Lieberman, J. (2005). Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial. Schizophrenia Research, 80(1), 1–8.
Synofzik, M., & Clausen, J. (2011). The ethical differences between psychiatric and neurologic dbs: Smaller than we think? AJOB Neuroscience, 2(1).
Synofzik, M., & Schlaepfer, T. E. (2011). Electrodes in the brain–ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders. Brain Stimulation, 4(1), 7–16. doi:10.1016/j.brs.2010.03.002.
The Alzheimer’s Study Group. (2009). A national Alzheimer’s strategic plan: The report of the Alzheimer’s Study Group. Washington, DC: Alzheimer’s Association.
Thies, W., & Bleiler, L. (2011). 2011 Alzheimer’s disease facts and figures. Alzheimer’s Dement, 7(2), 208–244. doi:10.1016/j.jalz.2011.02.004.
Torres, A. R., Prince, M. J., Bebbington, P. E., Bhugra, D., Brugha, T. S., Farrell, M., Singleton, N. (2006). Obsessive-compulsive disorder: Prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. American Journal of Psychiatry, 163(11), 1978–1985. doi:10.1176/appi.ajp.163.11.1978, 163/11/1978 [pii].
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Rush, A. J. (2006). Medication augmentation after the failure of SSRIs for depression. The New England Journal of Medicine, 354(12), 1243–1252. doi:10.1056/NEJMoa052964, 354/12/1243 [pii].
Voon, V., Krack, P., Lang, A. E., Lozano, A. M., Dujardin, K., Schupbach, M., Moro, E. (2008). A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson’s disease. Brain, 131(Pt. 10), 2720–2728. doi:10.1093/brain/awn214, awn214 [pii].
Weaver, F. M., Follett, K. A., Stern, M., Luo, P., Harris, C. L., Hur, K., Reda, D. J. (2012). Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes. Neurology, 79(1), 55–65. doi:10.1212/WNL.0b013e31825dcdc1, WNL.0b013e31825dcdc1 [pii].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Christopher, P.P., Dunn, L.B. (2015). Risk and Consent in Neuropsychiatric Deep Brain Stimulation: An Exemplary Analysis of Treatment-Resistant Depression, Obsessive-Compulsive Disorder, and Dementia. In: Clausen, J., Levy, N. (eds) Handbook of Neuroethics. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4707-4_31
Download citation
DOI: https://doi.org/10.1007/978-94-007-4707-4_31
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4706-7
Online ISBN: 978-94-007-4707-4
eBook Packages: Humanities, Social Sciences and Law